ReoPro Injektionslösung

Country: Շվեյցարիա

language: իտալերեն

source: Swissmedic (Swiss Agency for Therapeutic Products)

active_ingredient:

abciximabum

MAH:

Janssen-Cilag AG

ATC_code:

B01AC13

INN:

abciximabum

pharmaceutical_form:

Injektionslösung

composition:

abciximabum 2 mg, dinatrii phosphas dihydricus, natrii dihydrogenophosphas monohydricus, natrii chloridum, polysorbatum 80, aqua ad iniectabilia q s. annuncio solutionem pro 1 ml.

therapeutic_group:

Biotechnologika

therapeutic_area:

Perkutane Koronarintervention

authorization_date:

1995-10-17